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ABSTRACT: In Yajur Vedhika, “Panchakavvyam”, an indigenous preparation, is referred to 
have anticarcinogenic property.  In firbosarcoma, Panchakavvyam has been tried, which on 
feeding promotes longevity of rats.  The advantageous effect of the drug is substantial, so we 
tried to study the lipid changes in serum of both control and experimental animals.  A 
significance increase in free cholesterol and phospholipids (p<0.001) ; total cholesterol and free 
fatty acids; a significant decrease in (p<0.001) ester cholesterol; and triglycerides.  Among the 
enzymes, a significant increase in cholesterol ester hydrolase are observed.  On panchakavvyam 
administration to the humour-bearing rats, a significant increase in ester cholesterol and 
triglycerides; and a gradual decrease in total cholesterol, free cholesterol, phospholipids and 
free fatty acids; and a significant decrease in cholesterol ester synthetase and an increase in the 
level of cholesterol ester. 
 
INTRODUCTION 
 
The drug “Panchakavvyam” reported to be 
an anticarcinogenic agent in yajur Vedhika
24 
has been made to reverse cachexia and to 
selectively deprive the tumour cells for 
catabolishing the nutrients, and the structural 
components of the host cells which are 
necessary for the normophysiology of 
tumour locus, by feeding a ketogenic 
regimen.  If tumour bearing mice are 
provided with an exogenous supply of fatty 
acids, ketonemia is observed suggesting no 
impairment of the liver in its ability to 
synthesize ketone bodies
3,13. 
 
The cachectic syndrome is characterized by 
depletion of the host muscle and adipose 
mass and a reduction in insulin secretion
7,21 
accompanied by a lower serum glucose level 
and an elevation in serum unesterified fatty 
acid levels
1. 
 
A low carbohydrate ketogenic diet might be 
expected to prevent host catabolism during 
cachexia and, in addition, reduces the rate of 
growth of tumours which depend on glucose 
for energy
22. 
 
Normally, plasma lipid levels are governed 
by tissue metabolism  and permeability of 
cell membranes to lipid constituents.  While 
lipid changes with dietary fat modifications 
have been restricted to plasma, liver, aortic 
smooth muscles cells and fibroblasts in 
animals
6. 
 
Thus panchakavvyam is capable of 
reversing the adverse effects of cachexia, 
which results in prolonging the survival time 
of the tumour-bearing rats. Pages 148 - 153 
Kumar et al have reported the changes 
observed in histopathology, serum marker 
enzymes, and plasma glycoproteins in 
fibrosarcoma and in treatment with 
panchakavvyam in rats
11.  This article deals 
with the effect of panchakavvyam on the 
lipid levels and their related enzymes in 
fibrosarcoma bearing rats of about 95 – 105 
g. 
 
Methods 
 
Animals used :  Adult, Wistar, male rats 
were obtained from King institute of 
Preventive Medicine, Madras, India.  The 
pelleted animal feed marketed by M/s. 
Hindustan Lever Ltd., India was fed to the 
rats with water and libitum.  The animals 
were housed in well ventilated, hygienic 
cages. 
 
Tumer induction :  Animals were 
transplanted with 20 – methyl cholanthrene 
induced  cell line, 1 ml of 10 percent cell 
suspension containing 10 cells in 
physiological saline, using a 16 gauge sterile 
needle14 subcutaneously into the axilary 
region. 
 
The drug preparation :  Panchakavvyam 
was prepared  by mixing cow’s urine, 
cowdung (freshly voided), milk, curd and 
ghee in the proportion of 3:3:1.5:10:1.5 
(V/V) under aseptic conditions and stored at 
4
0C, throughout the experimental period.   
Five millilitre of the drug was given orally, 
for 40 days, from  the 9
th  day of 
transplantation, using a mouth tube. 
 
Experimental set-up :  The experimental 
rats were divided into 3 groups, 
 
Group I  : Normal rats 
 
Group II  : Animals transplanted with 
fibrosarcoma cell line 
 
Group III  :Animals transplanted with 
fibrosarcoma cell line and treated with 
Panchakavvyam. 
 
After 40 days of drug administration, daily 
the animals were sacrified and the following 
parameters were estimated in serum of 
control and experimental animals. 
 
Protein was estimated according to the 
method  of Lowry et al
12  cholesterol ester 
synthetase
9, cholesterol ester hydrolase
10, 
total cholesterol and ester cholesterol
16, 
triglyceride
19, phospholipid
20 free fatty acid
8 
were estimated. 
 
For all the statistical evaluations, “student’s 
T test” was used, to detect significant 
changes associated with various groups. 
 
Results and Discussions 
 
Depletion of the host muscle protein, 
glycogen and lipids accompanied by a lower 
serum glucose level and an elevation in free 
cholesterol, and a decrease in neutral fat 
have been reported
1.  Hence, the loss of 
major nutrients, particularly, excessive 
catabolism of lipids, leads to cachexia and 
the chronic and acute cachectic conditions 
finally leads to death in rats
21. 
 
Table 1 shows the individuals lipid levels in 
both control and experimental animals. 
Individual lipids, namely total cholesterol, 
ester cholesterol, free cholesterol, 
triglycerides, phospholipids and free fatty 
acids are studied in control and experimental 
rats. 
 
It is observed from table 1, a significant 
increase in free cholesterol and 
phospholipids (p < 0.001); total cholesterol 
(p<0.01) significance; and free fatty acid 
(p<0.05) in group II animals.  Hyperlipemia Pages 148 - 153 
associated with cancer has been attributed to 
the mobilization of fat from the stores, both 
to meet the increased energy demands of the 
tumour bearing host and to supply 
unsaturated fatty acids for the maintenance 
of high concentration of phospholipids with 
in the tumour.  The lipemia subsides 
terminally and it is found that the fat stores 
are empty
2  to meet increased caloric 
requirements of the host, during acute 
cancer condition. 
 
In contrast, the table 1 shows a decrease 
ester cholesterol (p < 0.001) and 
triglycerides (p < 0.05) in Group II animals 
when compared with Group I, and 
significant increase  in  ester  cholesterol          
(p < 0.001), triglyceride in Group III when 
compared with Group II. 
 
Panchakavvyam treated Group III rats, also 
show a decrease in the levels of total 
cholesterol (p < 0.05), ester cholesterol (p < 
0.001), free cholesterol (p < 0.001), 
phospholipids and free fatty acids in serum. 
 
Table 2 shows the change in enzyme levels, 
namely, cholesterol ester synthetase and 
cholesterol ester hydrolase in serum of both 
control and experimental rats.  In Group II 
animals, a significant increase in cholesterol 
ester synthetase (p < 0.001) and a decrease 
in cholesterol ester hydrolase (p < 0.01) is 
observed.  In contrast, Panchakavvyam 
administered Group III animals, show 
decrease in cholesterol ester synthetase (p < 
0.01) and gradual increase in Cholesterol 
ester hydrolase (p < 0.005). 
 
In group II animals, CEH/CES ratio is 
markedly decreased when compared with 
Group I and Group III animals. 
 
Elevation of plasma cholesterol mainly free 
cholesterol was observed in tumour induced 
rats.  The  high level of free cholesterol 
might have been due to low activity of 
lecithin cholesterol acyl transferase (LCAT) 
which is responsible for generating a major 
portions of cholesterol esters.  The 
decreased ester cholesterol and increased 
free cholesterol levels in plasma indirectly 
aids the rapid multiplication of already 
proliferating cells
18.  In rat models, 
cholesterol levels are increased in cancer 
cells due to enhanced cholesterogenesis
17.  
In the metabolic turnover via hexose 
monophosphate shunt pathway is also 
increased to provide NADPH (Reduced 
nicotinamideadenine dinucleotide 
phosphate) for cholesterol synthesis and 
ribolse phosphate synthesis for augmented 
nucleic acid synthesis.  
 
The elevated level of free fatty acids could 
have contributed to the elevated triglyceride 
level in liver and kidney.  The elevated 
plasma triglyceride level observed in tumour 
induced rats might have been partially due 
to lipoprotein lipase
15.  Stimulation of lipid 
peroxidation has been reported to influence 
lipid metabolism in the biological system 
which can cause tumours
4. 
 
The synthesized cholesterol is rapidly 
esterified to ester cholesterol by cholesterol 
ester synthetase (CES), thus reducing the 
free cholesterol level which will otherwise 
inhibit the rate of limiting enzyme hydroxyl 
methyl glutaryl coenzyme A (HMG CoA) 
reductase in cancer cells
5.  CES is increased 
and CEH is decreased substantially in 
tumour induced experimental animals when 
compared with controls.   The CEH/CES 
ratio is decreased.  Elevation in plasma 
cholesterol is mediated through increased 
turnover and is influenced by relative 
balance between CEH/CES in the peripheral 
cells. 
 
 Increased activity of CES inside 
proliferating fibrosarcoma cells, may cause Pages 148 - 153 
increased cholesterogenesis and rapid 
multiplication of already proliferating cells.  
The above hypothesis is supported by 
similar observation of Rao et al
18 in acinar 
cell carcinoma of pancreas. 
 
Panchakavvyam is comprised of chiefly 
lipid and protein and  low  carbohydrates.  
Since the drug contains high far, it supplies 
the fat required by the tumour –  bearing 
animals thus preventing them from going in 
for cachectic syndrome and prolonging the 
life span. 
 
Thus, large quantities of exogenous 
substrates are associated with an increase 
metabolic rate and stimulation of tumour 
growth.  By increasing the lipid contribution 
to the nutritional regimen, it is possible to 
prevent the host weight loss while reducing 
tumour size
23. 
 
Accordingly, the drug, panchakavvyam, 
which fulfills the specific requirement to 
suppress the tumour development 
nutritionally, can be considered to be having 
anticarcinogenic properties. 
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Table 1 
 
Lipid levels in Serum of both control and experimental groups at the end of the 
experimental period. n = 6 animals in each group. 
 
Particulars  Group I  Group II  Group III 
Total Cholesterol 
 
Free Cholesterol 
 
Ester Cholesterol 
 
Triglyceride 
 
Phospholipid 
 
Free Fatty acid 
84.70 . 12.40 
 
38.09 . 5.28 
 
46.61 . 6.34 
 
40.96 . 5.07 
 
1.25 . 0.18 
 
5.63 . 0.82 
110.60 . 10.34
a@ 
 
97.62 . 11.94
a# 
 
12.68 . 2.38
a# 
 
33.26 .  4.32
a* 
 
3.02 .  0.29
a# 
 
7.00 . 1.02
a* 
95.30 . 8.87
b* 
 
71.43 . 9.45
b@ 
 
26.87 . 3.19
b# 
 
37.52 . 5.41 
 
2.29 . 0.21
b@ 
 
5.90  . 0.86 
 
 
Values are expressed as Mean  . SD in mg/dl of Serum. 
 
Comparisons made between groups are: 
 
a – Group I and II : b – Group II and III 
 
Statistical significance : *p < 0.05 ; @p < 0.01; #p < 0.001. 
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Table 2 
 
Cholesterol ester synthetase (CES) and cholesterol ester hydrolase (CEH) levels both in 
control and experimental period. n = 6 animals in each group. 
 
Enzynes  Group I  Group II  Group III 
Serum (Units/litre) 
 
Serum CEH (Units/liter) 
 
(CEH/CES) * 10
3 
6.15 . 0.940 
 
5.79 . 0.630 
 
941.46 . 129.79 
 
 
9.25 . 1.31
a@ 
 
4.41 . 0.56
a@ 
 
476.76 . 60.38
a# 
 
 
7.85 . 0.47
b* 
 
4.90 . 0.79 
 
724.20 . 98.70
b@ 
 
 
 
Values are expressed as Mean  . SD  
 
Enzyme units are expressed as nanomoles of cholesterol liberated or esterified/mg of 
protein/hour : all at 37
oC 
 
Comparison made between groups are : a – Group I and II : b – Group II and III 
 
Statistical significance : *p < 0.05 ; @p < 0.01; #p < 0.001. 
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